Stock listing

VCYT Stock Price, News, Filings & Events — Veracyte, Inc.

Selected listing: VCYT · NASDAQ · USD · US

This page tracks Veracyte, Inc.'s VCYT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VCYT:NASDAQ. VCYT:NASDAQ is the stock-level entry point for investors researching Veracyte, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Veracyte, Inc. (Ticker: VCYT) is a public company operating in the American market, with a market capitalization of approximately $4.5 billion. The company specializes in genomic diagnostics, providing innovative solutions to improve patient care. Veracyte focuses on advancing precision medicine through its advanced technologies and products.

VCYT:NASDAQUSDUSUpdated September 11, 2026
Veracyte, Inc. logo
Ticker
VCYT:NASDAQ
Asset type
Stock
Market cap
$3.29B
Sector
Health Technology
Industry
Medical Specialties
Exchange
NASDAQ
Currency
USD

Veracyte, Inc. VCYT:NASDAQ stock context

This page tracks Veracyte, Inc.'s VCYT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VCYT:NASDAQ. VCYT:NASDAQ is the stock-level entry point for investors researching Veracyte, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Veracyte, Inc. (Ticker: VCYT) is a public company operating in the American market, with a market capitalization of approximately $4.5 billion. The company specializes in genomic diagnostics, providing innovative solutions to improve patient care. Veracyte focuses on advancing precision medicine through its advanced technologies and products.

Latest news from Veracyte, Inc.

All Veracyte, Inc. news →

Veracyte, Inc. earnings calls

Research Veracyte, Inc.

Alternate listings